olimstgon.blogspot.com
The money was granted in collaboratiojn withthe U.S. Army Medical Research and Materiel Command and the througbthe Ft. Detrick Technology Transfer Initiative. The purposer of the technology transfer program is to raise awareness of new and developing technologies and funding them to transitiomn as viable projectsfor follow-o funding in the market place. Each company that receiveed funding was awardedapproximately $50,000 betweenb March 2008 and May making up the initiative’se second round of financialo awards since its $750,00p program extension. The funds for the program’a second phase were secured by Sen. Barbara Mikulski, and Rep. Roscoe G. Bartlett, R-Md. “The [Ft.
Detrick Technology Transfer program is enabling area businesses to harnesds the technologies being developed at Fort Detriclk and apply them to the commercial sector,” said Mikulski. “This will lead to new productss that have the power to create jobs andsave lives.” Mikulskii announced the first phase of the tech transfer progran in March 2005 when 11 companiesx received funding. in Rockville: The companyg is developing a health care technology called miTag which is a scalable wireless sensor solutionm for improvingpatient flow. in Frederick: The company is developing a technology called the GeNova Screento identify, and produce antibody-like molecules.
in The company is developintgan on-demand biotech products includingb a combination vaccine against plague and anthrax. BioAssay Works LLC in The company is developinyga lateral-flow visual diagnostic test to detect and differentiate singled sample multiple pathogenic poxviruses, including vaccinia, and monkeypox. in The company is safety-testin g a medical product calledd ClotFoam, which is a non-compressible, intracavitary hemostati c agent. CynerGene IDMP in Frederick: The compang is developing, validating and implementing a supplemental diagnosisof Malaria, HIV, and Denguwe using its Infectious Disease Multiplex Panel which could allow for creationn of biosensors.
LLC in Baltimore: The company is developin g required components and system framework to enablee conversational interfaces for telemedicine Such tools would allow professionaol medics touse voice, gesture, and othet human-- computer interactions to access and document information in electronic medicak records. in Rockville: The company is developing technologyg to preserve mammalian cells in dried format that can easilgbe re-hydrated for a variety of uses. LLC in The company is evaluating the effect of Imagilin patentec probiotics as a food supplement to enhance the immun e responsiveness of guinea pigs upon immunizatioh or challenge withvirulent pathogens.
The evaluation will suggest the ability of Imagilin patented probioticsz to enhance the immunization ofa vaccine. in The company is developing micropatterned substrates for viralpinfectivity assays. Juxtopia in Baltimore: The companh is customizing its Wearablw Assistance and SituationalAwareness (WASA) goggles and services to allow U.S. Army combat medics to access and document informatiobn to electrical medical recordsvia hands-free voice-requestsz and voice-responses. in Baltimore: The company is developinv cell therapies to treat brain and spinalcord injuries.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment